Background illustration for clinical trials search

Paid Clinical Trials Warwick

Discover 491 paid clinical trials in Warwick, Rhode Island. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

for
Ovarian Cancer, Lung Adenocarcinoma, Endometrial Cancer,
Location: Providence RI, Boston MA, Montreal, Fairfax VA, Toronto,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT05797168

Phase 1, Phase 2, Recruiting

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

for
Advanced or Metastatic Non-small Cell Lung Cancer
Location: Providence RI, Baltimore MD, Cleveland OH,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06996782

Phase 1, Phase 2, Recruiting

Study of AZD4956 as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homologous Recombination Deficient Solid Tumours

for
Solid Tumours
Location: Providence RI, New York NY, Fairfax VA, Houston TX
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07446855

Phase 1, Phase 2, Recruiting

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

for
Biliary Tract Cancer
Location: Providence RI, Hartford CT, New Haven CT, Mineola NY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07221253

Phase 3, Recruiting

A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer

for
Prostate Cancer
Location: Providence RI, Commack NY, Quebec, Grand Rapids MI,
Sponsor: AstraZeneca

Sex: Male

Age: 18+

Code: NCT07192614

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of DS5361b in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Providence RI, Fairfax VA, Sarasota FL, Irving TX,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT07182591

Phase 1, Recruiting

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

for
Prostate Cancer
Location: Providence RI, Plymouth MA, New York NY, Hackensack NJ,
Sponsor: AstraZeneca

Sex: Male

Age: 18+

Code: NCT06952803

Phase 3, Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for
Cardiovascular Disease
Location: Providence RI, Brookline MA, Boston MA, Waterbury CT,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase 3, Recruiting

A Study of AZD3470, a PRMT5 Inhibitor, Given as Monotherapy and in Combination in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors

for
Advanced Solid Tumors That Are MTAP Deficient
Location: Providence RI, New Haven CT, Baltimore MD, Fairfax VA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06130553

Phase 1, Phase 2, Recruiting

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

for
Heart Failure and Impaired Kidney Function
Location: Providence RI, Boston MA, The Bronx NY, Clifton Park NY,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06307652

Phase 3, Recruiting

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

for
Breast Cancer
Location: Providence RI, New Haven CT, Stony Brook NY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06103864

Phase 3, Recruiting

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

for
Mild Cognitive Impairment, Alzheimer's Disease,
Location: East Providence RI, Toronto, Farmington Hills MI,
Sponsor: GAP Innovations, PBC

Sex: All

Age: 60 - 70+

Code: NCT06584357

Recruiting

Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer

for
Advanced Breast Cancer
Location: East Providence RI, Nashville TN, St Louis MO
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT07427394

Phase 2, Recruiting

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

for
Chronic Kidney Disease and Hypertension
Location: East Providence RI, New Bedford MA, Worcester MA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06742723

Phase 3, Recruiting

A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)

for
Attention Deficit Disorder With Hyperactivity (ADHD)
Location: East Providence RI, North Canton OH, Memphis MI,
Sponsor: Alkermes, Inc.

Sex: All

Age: 18 - 65

Code: NCT07755410

Phase 2, Recruiting

Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building

for
Alcohol Use Disorder (AUD), PTSD
Location: Providence RI
Sponsor: University of Rhode Island

Sex: All

Age: 18+

Code: NCT07217795

Recruiting

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

for
Acute Myeloid Leukaemia (AML)
Location: Providence RI, Morristown NJ, Philadelphia PA,
Sponsor: Moleculin Biotech, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06788756

Phase 2, Phase 3, Recruiting

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

for
Metastatic Prostate Cancer
Location: Providence RI, Boston MA, New York NY, Detroit MI,
Sponsor: AstraZeneca

Sex: Male

Age: 18 - 70+

Code: NCT07181161

Phase 1, Phase 2, Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for
Acute Coronary Syndrome
Location: Providence RI, Hartford CT, New Haven CT,
Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase 3, Recruiting

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Waterford CT, Burlington MA, Glastonbury CT, Peabody MA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06058377

Phase 3, Recruiting